Pacer Advisors’s DermTech, Inc. Common Stock DMTK Stock Holding History

Pacer Advisors’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-860	Closed	-$44K	–	1577
2021 Q1	$44K	Buy	+860	New	+$45K	﹤0.01%	1455

Other funds holding DMTK

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ICM

ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Pacer Advisors's DMTK Position: Q2 2021 in Review

Pacer Advisors sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2021, closing a stake of 860 shares — an estimated $44K sold.

Pacer Advisors first reported a position in DMTK in Q1 2021 and held it in 1 quarter. The position peaked at $44K in Q1 2021. 176 funds tracked by Wall St. Rank hold DMTK as of Q2 2021.

Pacer Advisors reported no remaining DermTech, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Pacer Advisors sold 860 DermTech, Inc. Common Stock shares in Q2 2021, an estimated $44K.
Pacer Advisors first reported a position in DermTech, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
Pacer Advisors's DermTech, Inc. Common Stock position peaked at $44K in Q1 2021.
176 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2021.

Based on Pacer Advisors's 13F filing for Q2 2021, filed 21 Jul 2021.